Pale Fire Capital SE’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-47,734
| Closed | -$65.9K | – | 71 |
|
|
2025
Q1 | $65.9K | Buy |
47,734
+4,011
| +9% | +$5.54K | 0.01% | 56 |
|
|
2024
Q4 | $133K | Hold |
43,723
| – | – | 0.03% | 38 |
|
|
2024
Q3 | $218K | Buy |
43,723
+22,150
| +103% | +$110K | 0.03% | 40 |
|
|
2024
Q2 | $126K | Hold |
21,573
| – | – | 0.01% | 33 |
|
|
2024
Q1 | $171K | Hold |
21,573
| – | – | 0.02% | 36 |
|
|
2023
Q4 | $126K | Buy |
21,573
+4,998
| +30% | +$29.1K | 0.02% | 57 |
|
|
2023
Q3 | $42.4K | Buy |
+16,575
| New | +$42.4K | ﹤0.01% | 68 |
|